WebRandomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and … Web5500 Background: We conducted a phase III non-inferiority trial comparing upfront primary debulking surgery (PDS) and neoadjuvant chemotherapy (NAC) for stage III/IV ovarian, …
JCOG0305, Randomized trial of chemoradiotherapy and adjuvant ...
WebJCOG0201 defined "radiological early peripheral lung adenocarcinoma" J Thorac Oncol. 2011 Aug;6(8):1452-3. doi: 10.1097/JTO.0b013e318223c415. WebJCOG0305, Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine ACNU versus nimustine plus procarbazine for newly diagnosed anaplastic … knowledge literature about life insurance
第17回 臨床試験から見えるがん診療の変遷【脳腫瘍編・前編】
WebPurpose Glioblastoma (GBM) is one of the worst cancers in terms of prognosis. Standard therapy consists of resection with concomitant chemoradiotherapy. Resistance to nimustine hydrochloride (ACNU), an alkylating agent, has been linked to methylguanine DNA methyltransferase (MGMT). Daily administration of procarbazine (PCZ) has been … Web1 gen 2016 · Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305). Cancer Chemother Pharmacol 2013; 71: 511 – 21 doi: 10.1007/s00280-012-2041-5 pmid: 23228988 WebDive into the research topics of 'Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly … redcar playland